Alyeska Investment Group’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,667	Closed	-$1.1M	–	821
2021 Q2	$1.1M	Buy	6,667 +3,334	+100%	+$552K	0.01%	573
2021 Q1	$643K	Buy	+3,333	New	+$643K	0.01%	631